Cemtrex Signs Letters of Intent for Two Strategic Acquisitions in Robotics and Aerospace
August 25, 2025
Technology
-
-
LivePerson Announces AWS Integration to Unify Voice and Digital Customer Experiences
August 25, 2025
-
WISeKey Unveils Its Next-Generation WISeID: A Fully Decentralized Identity Platform for People and Objects
August 25, 2025
-
Theratechnologies Announces Filing of Special Meeting Materials and Receipt of Interim Order in Relation to its Acquisition by CB Biotechnology, an Affiliate of Future Pak
August 18, 2025
-
FDA Grants Soligenix Orphan Drug Designation for the Treatment of Behçet’s Disease after Reviewing Recent Phase 2 Clinical Study Results
August 18, 2025
-
VivoPower’s Tembo e-LV Subsidiary on Track for $200 Million Enterprise Value Investment from Energi Holdings via SPAC Transaction
August 18, 2025
-
Sequans Announces Strategic Plan to Acquire 100,000 Bitcoin by 2030
August 14, 2025
-
VERSES® Unveils Robotics Architecture that Works Without Pre-Training
August 14, 2025
-
ZenaTech Signs Offer to Acquire a Flight School Enabling Complex BVLOS Missions and Potential Drone as a Service (DaaS) US Government and Military Contracts
August 14, 2025
-
ZenaTech Reports Over 500% Increase in Year-Over-Year Revenue for Second Quarter of 2025 and Over 250% Increase in Revenue for the First Six Months of Year
August 12, 2025
-
Equillium Announces Up to $50 Million Financing to Advance EQ504, a Novel Aryl Hydrocarbon Receptor Modulator, into the Clinic
August 11, 2025
-
Aditxt and Crypto.com Sign Agreement for Custodial Crypto Account, Announce ADTX Share Access on Crypto.com as Part of the Larger bitXbio(TM) Initiative
August 11, 2025
-
ZenaTech Acquires Cardinal Civil Resources, a Virginia-Based Land Surveying and Engineering Firm Serving Three States and Large Customers Including US Department of Transportation
August 7, 2025
-
Oblong Deploys $8M in Fully Staked $TAO to Capitalize on Decentralized AI Surge
August 7, 2025
-
Bioxytran’s Breakthrough Broad-Spectrum Antiviral Technology Poised to Revolutionize Respiratory Infection Treatment
August 7, 2025
-
Tevogen Receives $1 Million to Accelerate AI-Driven Drug Discovery; Remains Well Capitalized to Execute Growth Strategy
August 7, 2025